Accéder directement au contenu Accéder directement à la navigation

I2MC - Institut des maladies métaboliques et cardiovasculaires

2014-2015 (vague A)

Type de rapport
Rapport d’évaluation d’une entité de recherche
Campagne d'évaluation
2014-2015 (vague A)
Date de publication
2015-07-16
Etablissement(s)
Institut national de la santé et de la recherche médicale - INSERM, Université Toulouse 3 - Paul Sabatier - UPS
Domaine scientifique
Biologie, médecine et santé
Discipline
SVE Sciences du vivant et environnement
SVE5 Physiologie, Physiopathologie, Cardiologie, Pharmacologie, Endocrinologie, Cancer, Technologies Médicales
Panel ERC
LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome
Nom des équipes de l'unité
STROMA-VASCULAR CELLS OF ADIPOSE TISSUE
INTESTINAL RISK FACTOR, DIABETES, DYSLIPIDEMIA
PLATELET PRODUCTION AND FUNCTIONS, SIGNALING AND PHOSPHOIONOSITIDES
RENAL FIBROSIS: MECHANISMS AND DETECTION
SIGNALING AND PATHOPHYSIOLOGY OF HEART FAILURE
ROLE OF BIOACTIVE PEPTIDES IN CARDIAC REMODELING RELATED TO OBESITY
MOLECULAR REGULATION OF (LYMPH) ANGIOGENIC FACTORS IN VASCULAR DISEASES
PL SIGNALING IN AGING AND METABOLIC DISORDERS
ADIPOCYTE SECRETIONS, OBESITIES AND RELATED DISEASES
OBESITY RESEARCH LABORATORY
HIGH DENSITY LIPOPROTEIN (HDL) AND PI3K SIGNALING IN ATHEROSCLEROSIS
STROMAL MICROENVIRONMENT AND HEART FAILURE
OBESITY AND HEART FAILURE: MOLECULAR AND CLINICAL INVESTIGATIONS
MOLECULAR AND CLINICAL DETERMINANTS OF CARDIAC ARCHITECTURE
OPTIMIZATION OF ESTROGEN RECEPTOR MODULATION IN MEDICINE
LIPIDS, PEROXIDATION, SIGNALING AND VASCULAR DISEASE
Mots-clés
Langue de rédaction du rapport
Anglais

Partager